Literature DB >> 26626060

What's new in cell therapies in ARDS?

Shahd Horie1,2, Gerard F Curley3, John G Laffey4,5.   

Abstract

Mesh：

Year:  2015        PMID： 26626060     DOI： 10.1007/s00134-015-4140-3

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  16 in total

1.  Study of Bone Marrow and Embryonic Stem Cell-Derived Human Mesenchymal Stem Cells for Treatment of Escherichia coli Endotoxin-Induced Acute Lung Injury in Mice.

Authors:  Qi Hao; Ying-Gang Zhu; Antoine Monsel; Stephane Gennai; Travis Lee; Fengyun Xu; Jae-Woo Lee
Journal:  Stem Cells Transl Med       Date:  2015-05-21       Impact factor: 6.940

2.  Adipose Tissue-Derived Mesenchymal Stem Cells Attenuate Pulmonary Infection Caused by Pseudomonas aeruginosa via Inhibiting Overproduction of Prostaglandin E2.

Authors:  Yan-Xiong Mao; Jin-Fu Xu; Eric J Seeley; Xiao-Dan Tang; Lu-Lu Xu; Ying-Gang Zhu; Yuan-Lin Song; Jie-Ming Qu
Journal:  Stem Cells       Date:  2015-05-13       Impact factor: 6.277

3.  TSG-6 as a biomarker to predict efficacy of human mesenchymal stem/progenitor cells (hMSCs) in modulating sterile inflammation in vivo.

Authors:  Ryang Hwa Lee; Ji Min Yu; Andrea M Foskett; Grant Peltier; John C Reneau; Nikolay Bazhanov; Joo Youn Oh; Darwin J Prockop
Journal:  Proc Natl Acad Sci U S A       Date:  2014-11-10       Impact factor: 11.205

4.  Mesenchymal stem (stromal) cells for treatment of ARDS: a phase 1 clinical trial.

Authors:  Jennifer G Wilson; Kathleen D Liu; Hanjing Zhuo; Lizette Caballero; Melanie McMillan; Xiaohui Fang; Katherine Cosgrove; Rosemary Vojnik; Carolyn S Calfee; Jae-Woo Lee; Angela J Rogers; Joseph Levitt; Jeanine Wiener-Kronish; Ednan K Bajwa; Andrew Leavitt; David McKenna; B Taylor Thompson; Michael A Matthay
Journal:  Lancet Respir Med       Date:  2014-12-17       Impact factor: 30.700

5.  Therapeutic efficacy of human mesenchymal stromal cells in the repair of established ventilator-induced lung injury in the rat.

Authors:  Mairead Hayes; Claire Masterson; James Devaney; Frank Barry; Steve Elliman; Timothy O'Brien; Daniel O'Toole; Gerard F Curley; John G Laffey
Journal:  Anesthesiology       Date:  2015-02       Impact factor: 7.892

6.  The secretome of induced pluripotent stem cells reduces lung fibrosis in part by hepatocyte growth factor.

Authors:  Amiq Gazdhar; Iwona Grad; Luca Tamò; Mathias Gugger; Anis Feki; Thomas Geiser
Journal:  Stem Cell Res Ther       Date:  2014-11-10       Impact factor: 6.832

7.  Apoptotic adipose-derived mesenchymal stem cell therapy protects against lung and kidney injury in sepsis syndrome caused by cecal ligation puncture in rats.

Authors:  Pei-Hsun Sung; Chia-Lo Chang; Tzu-Hsien Tsai; Li-Teh Chang; Steve Leu; Yung-Lung Chen; Chic-Chao Yang; Sarah Chua; Kuo-Ho Yeh; Han-Tan Chai; Hsueh-Wen Chang; Hong-Hwa Chen; Hon-Kan Yip
Journal:  Stem Cell Res Ther       Date:  2013       Impact factor: 6.832

8.  Clinical grade allogeneic human mesenchymal stem cells restore alveolar fluid clearance in human lungs rejected for transplantation.

Authors:  D F McAuley; G F Curley; U I Hamid; J G Laffey; J Abbott; D H McKenna; X Fang; M A Matthay; J W Lee
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-02-14       Impact factor: 5.464

9.  Human mesenchymal stem cells reduce the severity of acute lung injury in a sheep model of bacterial pneumonia.

Authors:  Sven Asmussen; Hiroshi Ito; Daniel L Traber; Jae W Lee; Robert A Cox; Hal K Hawkins; Daniel F McAuley; David H McKenna; Lillian D Traber; Hanjing Zhuo; Jennifer Wilson; David N Herndon; Donald S Prough; Kathleen D Liu; Michael A Matthay; Perenlei Enkhbaatar
Journal:  Thorax       Date:  2014-06-02       Impact factor: 9.139

10.  Efficient generation of lung and airway epithelial cells from human pluripotent stem cells.

Authors:  Sarah X L Huang; Mohammad Naimul Islam; John O'Neill; Zheng Hu; Yong-Guang Yang; Ya-Wen Chen; Melanie Mumau; Michael D Green; Gordana Vunjak-Novakovic; Jahar Bhattacharya; Hans-Willem Snoeck
Journal:  Nat Biotechnol       Date:  2013-12-01       Impact factor: 54.908
View more
  4 in total

Review 1.  Review of Trials Currently Testing Stem Cells for Treatment of Respiratory Diseases: Facts Known to Date and Possible Applications to COVID-19.

Authors:  Fernanda Majolo; Guilherme Liberato da Silva; Lucas Vieira; Luís Fernando Saraiva Macedo Timmers; Stefan Laufer; Márcia Inês Goettert
Journal:  Stem Cell Rev Rep       Date:  2021-02       Impact factor: 5.739

2.  Safety and efficacy of multipotent adult progenitor cells in acute respiratory distress syndrome (MUST-ARDS): a multicentre, randomised, double-blind, placebo-controlled phase 1/2 trial.

Authors:  G Bellingan; F Jacono; J Bannard-Smith; D Brealey; N Meyer; D Thickett; D Young; A Bentley; B J McVerry; R G Wunderink; K C Doerschug; C Summers; M Rojas; A Ting; E D Jenkins
Journal:  Intensive Care Med       Date:  2021-11-23       Impact factor: 41.787

3.  Hypercapnic acidosis induces mitochondrial dysfunction and impairs the ability of mesenchymal stem cells to promote distal lung epithelial repair.

Authors:  Nicola Fergie; Naomi Todd; Lana McClements; Danny McAuley; Cecilia O'Kane; Anna Krasnodembskaya
Journal:  FASEB J       Date:  2019-01-16       Impact factor: 5.191

Review 4.  State of the Art Review of Cell Therapy in the Treatment of Lung Disease, and the Potential for Aerosol Delivery.

Authors:  Hosanna Brave; Ronan MacLoughlin
Journal:  Int J Mol Sci       Date:  2020-09-03       Impact factor: 5.923
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.